While a role of UFM1 for PD-L1 in the nervous system remains unknown, emerging evidence suggests that the PD-L1/PD-1 immune checkpoint pathway plays a critical role in modulating neuroinflammation, microglial function, amyloid-β clearance and p-tau clearance in AD [215, 216, 249]. This evidence concerns the gene CD274 and Alzheimer disease.